Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2026-01-28 @ 7:54 PM
Study NCT ID:
NCT06127095
Status:
COMPLETED
Last Update Posted:
2024-12-18
First Post:
2023-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess New Participant's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-28
Completion Date Type:
ACTUAL
First Submit Date:
2023-11-07
First Submit QC Date:
None
Study First Post Date:
2023-11-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-17
Last Update Post Date:
2024-12-18
Last Update Post Date Type:
ACTUAL